CABC Homepage
New Customer | Sign In
List of Popular Cases Newly Released Cases Faculty of Business and Economics Institutional Users Home Site Map
Advanced Search
 
Topic Index
Industry & Company Index
Most Popular Cases
Newly Released Cases
SME Cases Series
China Cases Series
India Cases Series
IT Industry Transformation Series
Cases in Chinese
Cases in Other Languages
Project SARS Rebound
Research Note Details:
Email to a friend
Chinese Medicine in an Emerging Market    
 
Product Ref: 05/236RN Company: N/A

Product Type: Research Note Industry: Pharmaceuticals & Biotechnology

Related Product(s): N/A
It was estimated in 2002 that the size of the traditional Chinese medicine (TCM) market in China would be around US$5 billion. A decade of Chinese regulatory reforms, Chinese pharmaceutical industry's liberalisation, changing Chinese lifestyle and demographics, and the Chinese pharmaceutical research and development facilities were factors explaining the huge TCM market potential in China. This case looks at the issues faced by multinationals wanting to enter this market.
Functional Area : Strategy & General Management

Issues: Healthcare Industry, Chinese Medicine, Emerging Markets, Market Entry, Strategy
Length: 20 pages Country: Hong Kong SAR

Pub. Year: 2005 Level of Difficulty: 1
         
This product type is available in the following language(s):      English   Simplified Chinese
         
Related Information: N/A
 
A web based copy of the research note can be found here.
If you are an educator and would like to obtain copies for classroom distribution please contact us at info@acrc.org.hk.